However, its crucial to consult your healthcare provider before making any adjustments
Batch: GF-CJCIPA10/10-B242 Key analytical results include: Ipamorelin Assay Content: 10.26 mg CJC-1295 (MOD GRF 1-29) Assay Content: 11.19 mg Ipamorelin Identification Retention Time: 0.994 CJC-1295 Identification Retention Time: 0.991 Ipamorelin Identification Spectrum: 996 CJC-1295 Identification Spectrum: 993 Purity: high purity confirmed for both peptides Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium
Ipamorelin helps promote natural hormonal signaling associated with growth hormone release and metabolic support , while being widely included in advanced peptide therapy protocols
For patients with established cardiovascular disease or high cardiovascular risk, it has also been shown to reduce the risk of heart attacks, strokes, and cardiovascular-related death
Visible particulate matter: Flakes, specks, or floating material that doesn't dissolve means the solution is compromised
Each plan includes structured medical oversight and is designed to align with your medical history, lifestyle factors, and long-term health priorities